the aid library

Filter

643

Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 3: establishing a framework for action

World Health Organization (WHO) World Health Organization (WHO) (2022) C_WHO

A framework for action provides a guide for those involved in the development of the multisectoral action plan. It starts with a wide-ranging vision and, through a series of increasingly specific intentions, brings into focus actions with measurable outcomes that can be taken to achieve that vision. ... more

Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 2: establishing stakeholder engagement and governance mechanisms 2022

World Health Organization (WHO) World Health Organization (WHO) (2022) C_WHO

To maintain a structured and well-organized implementation plan it is important to have a lead agency or sector. The ministry of health or a similar authority in government will be critical in facilitating development and implementation of the multi ... more

Gesundheitreport 2019 zurückgelassen — Wen unser Gesundheitssystem aussliesst: Krank und ohne medizinische Versorgung in Deutschland

Ärtze der Welt Ärtze der Welt (2019) C1

Indem sie die Deklaration „Universal health coverage: moving together to build a healthier world“ unterzeichnet hat, hat die Bundesregierung dieses Ziel im September 2019 noch einmal bekräftigt. Sie hat außerdem zugesichert, sich verstärkt um ... more

Drawing light from the pandemic: A new strategy for health and sustainable development

World Health Organization WHO, Regional Office of Europe (2021) C_WHO

Drawing light from the pandemic: A new strategy for health and sustainable development (2021) Available in English, French, German and Russian

Global Biodiversity Outlook 5 - arabic version

Convention on Biological Diversity (2020) C2

Global Biodiversity Outlook (GBO) is the flagship publication of the Convention on Biological Diversity (CBD). It is a periodic report that summarizes the latest data on the status and trends of biodiversity and draws conclusions relevant to the fur ... more

Audited Financial Statements for the year ended 31 December 2020

World Health Organization (WHO) World Health Organization (WHO) (2021) CC

WHO’s total revenue in 2020 was US$ 4299 million and total expenses were US$ 3561 million, resulting in a surplus of US$ 824 million, which includes finance revenue (e.g. interest and investment income) of US$ 86 million, representing increases of 38% and 15% in revenue and expenses respectively. ... more

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for ... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Toolkit for developing a multisectoral action plan for noncommunicable diseases: module 5: evaluating the implementation of a multisectoral action plan

World Health Organization (WHO) World Health Organization (WHO) (2022) C_WHO

Key stakeholders must be involved in the planning, implementation, monitoring and evaluation of NCD plans and programmes. Within a ministry of health there will be different types of stakeholders, such as programme managers and senior managers in de ... more

From plan to impact - Progress towards targets of the Global action plan on dementia

Alzheimer's Disease International (2018) C2

Progress towards targets of the Global action plan on dementia

Germany: health system review. Health Systems in Transition

Busse R, Blümel M World Health Organization (WHO) (2014)

The Health Systems in Transition (HiT) series consists of country-based reviews that provide a detailed description of a health system and of reform and policy initiatives in progress or under devel ... more

The Africa Health Transformation Programme 2015–2020 - A Vision for Universal Health Coverage

WHO Regional Office for Africa (2015) C_WHO

The new five-year agenda of WHO in Africa, The Africa Health Transformation Programme, 2015–2020: a vision for universal health coverage, is the strategic framework that will guide WHO’s contrib ... more

Increasing equity in health service access and financing: Health strategy, policy achievements and new challenges

Annear, Peter Leslie; Veasnakiry, Lo; Momoe Takeuchi World Health Organization (WHO) (2016) C_WHO

Policy note: Cambodia Health Systems in Transition.
The health system includes a mix of public and private providers. The use of private providers is much greater among the wealthy, while the u ... more

What are the challenges facing Myanmar in progressing towards Universal Health Coverage?

Phone Myint; Than Tun Sein; Cassels, Andrew World Health Organization (WHO) (2015) C_WHO

Policy Note #1: Myanmar Health Systems in Transition Policy Notes Series
The Government of the Republic of the Union of Myanmar is committed to achieving universal health coverage (UHC) by 2030 ... more

How can health equity be improved in Myanmar?

Phone Myint; Than Tun Sein; Cassels, Andrew World Health Organization (WHO) (2015) C_WHO

Policy Note #2: Myanmar Health Systems in Transition Policy Notes Series
Myanmar is a country in which people’s access to health services is determined more by where they live than their need ... more

How can the township health system be strengthened in Myanmar?

Phone Myint; Than Tun Sein; Cassels, Andrew World Health Organization (WHO) (2015) C_WHO

Policy Note #3: Myanmar Health Systems in Transition Policy Notes Series
A network of basic health facilities has been established in each of the 330 townships, covering both rural and urban ar ... more

Health System Review: Achievements and Challenges

Tangcharoensathien, Viroy; Patcharanarumol, Walaiporn; Panichkriangkrai, Warisa World Health Organization (WHO) (2016) C_WHO

Policy Note: Thailand Health Systems in Transition
By 2002, Universal Health Coverage was achieved through three public insurance schemes: the Civil Servant Medical Benefit Scheme (CSMBS) for civ ... more

Lesotho: National health strategic plan 2017-2022

Ministry of Health and Social Welfare (MoHSS), Kingdom of Lesotho (2016) C2

NHSP 2017- 2022 (Final draft)

CLIMATE CHANGE AND HEALTH IN MOZAMBIQUE: IMPACTS ON DIARRHEAL DISEASE AND MALARIA

USAID, ATLAS (2018) C1

This report outlines the results of a scientific study of the impacts of weather, climate variability, and climate change on health in Mozambique, with a focus on diarrheal disease and malaria.

Transforming health systems: the vital role of water, sanitation and hygiene

WaterAid (2018) C1

Tracking progress on health and climate change in Europe

Romanello M., van Daalen K., et al. (2021) C2

Left unabated, climate change will have catastrophic effects on the health of present and future generations. Such effects are already seen in Europe, through more frequent and severe extreme weather events, alterations to water and food systems, an ... more